Uniqure Stock Falls After Its Huntington’s Gene Therapy Lands At The FDA

The FDA said Monday it will make an approval decision on Uniqure’s Huntington’s gene therapy by May 1. But Uniqure stock fell.

The post Uniqure Stock Falls After Its Huntington’s Gene Therapy Lands At The FDA appeared first on Investor’s Business Daily.